Works matching IS 14642662 AND DT 2005 AND VI 6 AND IP 4

Results: 11

Influence of RANTES, SDF-1 and TGF-ß levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.

Published in:

2005

By:

Boulassel MR;
Smith GHR;
Edwardes MDB;
Young M;
Klein M;
Gilmore N;
MacLeod J;
LeBlanc R;
René P;
Allan J;
Lalonde RG;
Routy JP

Publication type:

Journal Article

In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 232, doi. 10.1111/j.1468-1293.2005.00282.x

By:

Perbost, I.;
Malafronte, B.;
Pradier, C.;
Santo, L. D. I.;
Dunais, B.;
Counillon, E.;
Vinti, H.;
Enel, P.;
Fuzibet, J. G.;
Cassuto, J. P.;
Dellamonica, P.

Publication type:

Article

Clinical characteristics and mid-term prognosis of acute coronary syndrome in HIV-infected patients on antiretroviral therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 240, doi. 10.1111/j.1468-1293.2005.00283.x

By:

Boccara, F.;
Ederhy, S.;
Janower, S.;
Benyounes, N.;
Odi, G.;
Cohen, A.

Publication type:

Article

Body shape and composition in HIV-infected women: an urban cohort.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 245, doi. 10.1111/j.1468-1293.2005.00284.x

By:

Karmon, S. L.;
Moore, R. D.;
Dobs, A. S.;
Keruly, J.;
Barnett, S.;
Cofrancesco Jr., J.

Publication type:

Article

Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxis.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 253, doi. 10.1111/j.1468-1293.2005.00289.x

By:

Cantey, P. T.;
Stephens, D. S.;
Rimland, D.

Publication type:

Article

Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 260, doi. 10.1111/j.1468-1293.2005.00305.x

By:

Bergersen, B. M.;
Sandvik, L.;
Ellingsen, I.;
Bruun, J. N.

Publication type:

Article

Influence of RANTES, SDF-1 and TGF-β levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 268, doi. 10.1111/j.1468-1293.2005.00306.x

By:

Boulassel, M . R .;
Smith, G. H. R.;
Edwardes, M. D. deB.;
Young, M.;
Klein, M.;
Gilmore, N.;
MacLeod, J.;
LeBlanc, R.;
René, P.;
Allan, J.;
Lalonde, R. G.;
Routy, J. P.

Publication type:

Article

Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 278, doi. 10.1111/j.1468-1293.2005.00307.x

By:

Stone, S. F.;
Price, P.;
French, M. A.

Publication type:

Article

Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 284, doi. 10.1111/j.1468-1293.2005.00308.x

By:

Antoniou, T.;
Raboud, J. M.;
Chirhin, S.;
Yoong, D.;
Govan, V.;
Gough, K.;
Rachlis, A.;
Loutfy, M. R.

Publication type:

Article

The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 291, doi. 10.1111/j.1468-1293.2005.00309.x

By:

Shah, M.;
Tierney, K.;
Adams-Huet, B.;
Boonyavarakul, A.;
Jacob, K.;
Quittner, C.;
Dinges, W. L.;
Peterson, D.;
Garg, A.

Publication type:

Article

New drugs.

Published in:

HIV Medicine, 2005, v. 6, n. 4, p. 225, doi. 10.1111/j.1468-1293.2005.00310.x

By:

Waters, L.;
Nelson, M. R.

Publication type:

Article